Peter Kiener

2014

In 2014, Peter Kiener earned a total compensation of $1.8M as Chief Science Officer at Sucampo Pharmaceuticals.

Compensation breakdown

Bonus$100,000
Non-Equity Incentive Plan$36,864
Option Awards$1,594,320
Salary$72,000
Other$9,030
Total$1,812,214

Kiener received $1.6M in option awards, accounting for 88% of the total pay in 2014.

Kiener also received $100K in bonus, $36.9K in non-equity incentive plan, $72K in salary and $9K in other compensation.

Rankings

In 2014, Peter Kiener's compensation ranked 4,913th out of 13,032 executives tracked by ExecPay. In other words, Kiener earned more than 62.3% of executives.

ClassificationRankingPercentile
All
4,913
out of 13,032
62nd
Division
Manufacturing
1,753
out of 4,966
65th
Major group
Chemicals And Allied Products
579
out of 1,686
66th
Industry group
Drugs
442
out of 1,365
68th
Industry
Pharmaceutical Preparations
352
out of 1,043
66th
Source: SEC filing on April 21, 2017.

Kiener's colleagues

We found five more compensation records of executives who worked with Peter Kiener at Sucampo Pharmaceuticals in 2014.

2014

Peter Greenleaf

Sucampo Pharmaceuticals

Chief Executive Officer

2014

Matthias Alder

Sucampo Pharmaceuticals

General Counsel

2014

Max Donley

Sucampo Pharmaceuticals

EVP, Global Human Resources, Information Technology and Strategy

2014

Peter Lichtlen

Sucampo Pharmaceuticals

Chief Medical Officer

2014

Andrew Smith

Sucampo Pharmaceuticals

Chief Financial Officer

In-depth

You may also like